Skip to main content

Dermatology News

News
Akorn Inc. is recalling more than 4000 boxes of Myorisan (isotretinoin) capsules, 20 mg. According to the January 8, 2020, US Food and Drug Administration (FDA) Enforcement Report, a customer reported a box labeled for 20-mg capsules contained a blister card of 40-mg capsules.  The recall is for…
News
Amneal Pharmaceuticals Inc. is recalling several batches of isotretinoin capsules, 10 mg, because tretinoin levels in the drug are slightly above specification limits, according to the November 20, 2019, US Food and Drug Administration (FDA) Enforcement Report.  The recall spans 2460 cartons of…
News
By Reuters Staff NEW YORK (Reuters Health) - Prescription-strength topical corticosteroids (TCs) can be purchased over the counter (OTC) in stores selling foreign products in many U.S. cities, new research shows. "These findings underscore the importance of asking about and physically examining…
Newsfeed
By Lisa Rapaport (Reuters Health) - Isotretinoin, a drug for severe chronic acne, has long been linked to miscarriages, birth defects and other serious problems, but a research review suggests much of data on the drug's safety, effectiveness and side effects may be unreliable. The analysis in the…
Newsfeed
By David Douglas NEW YORK (Reuters Health) - Treatment with ustekinumab (Stelara, Janssen Biotech) may be associated with noninfectious pneumonia, according to a report by the U.S. Food and Drug Administration (FDA). The drug was approved in 2009 for treating psoriasis-related conditions, and…
Newsfeed
By Reuters Staff ZURICH (Reuters) - Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria. Xolair is sold by both Novartis and Roche, but has lost patent…
News
Lupin Somerset is recalling 2712 bottles of fluocinolone acetonide topical solution USP, 0.01%, according to the October 31, 2018, US Food and Drug Administration (FDA) Enforcement Report. During stability testing, an out-of-specification result occurred for impurities. The recall affects 60-ml…
News
Dupilumab can significantly improve lung function and asthma exacerbation rates in children, according to new research from the phase 3 Liberty Asthma QUEST study. The study, authored by Jorge Maspero, MD, and colleagues, was presented on Tuesday, October 9, at the CHEST Annual Meeting 2018 in San…
News
By Manas Mishra (Reuters) - Valeant Pharmaceuticals International Inc's plaque psoriasis treatment Duobrii (halobetasol propionate and tazarotene) did not get approval from U.S. health regulators, a setback for the company which had high hopes for the lotion. The U.S. Food and Drug Administration…
News
The US Food and Drug Administration has approved expanding the indication for Cimzia (certolizumab pegol) to include adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The first Fc-free, PEGylated anti-tumor necrosis factor treatment option for…
Back to Top